November. 21st (Wednesday)

Special Lecture 1
Ralph Bartenschlager (Germany) : HCV Virology

Session 1
Cutting Edge Molecular Virology of HCV
1. Thomas F. Baumert (France) : Hepatitis C Virus Entry
2. Yoshiharu Matsuura (Japan) : TBA
3. Susan L Uprichard (U.S.A.) : Niemann-Pick C1–like 1 Cholesterol Absorption Receptor as a New Hepatitis C Virus Entry Factor
4. Takaji Wakita (Japan) : TBA

Session 2
Metabolic Aspects of Hepatitis C

Keynote lecture
1. Francesco Negro (Switzerland) : Metabolic Aspects of Hepatitis C

Clinical
2. Takumi Kawaguchi (Japan) : Hepatitis C and Diabetes
3. Chia-Yen Dai (Taiwan) : Hepatitis C and Lipid Metabolism

Basic

4. Ikuo Shoji (Japan) : HCV, Glucose and Glut2
5. Masaaki Korenaga (Japan) : Iron Metabolism in Hepatitis

Session 3
Hepatitis C in Asia
1. Teerha Piratvisuth (Thailand) : Hepatitis C in Thailand
2. Deepak Amarapurkar (India) : Hepatitis C in India
3. Junko Tanaka (Japan) : Hepatitis C in Japan
4. Hyon-Suk Lee (Korea) : Hepatitis C in Korea

November. 22nd (Thursday)

Special Lecture 2
Osamu Takeuchi (Japan) : Innate Immunity

Session 4
Pathogenesis of HCV-associated HCC
1. Taro Yamashita (Japan) : Cancer Stem Cells in Hepatocarcinogenesis
2. Pei-Jer Chen (Taiwan) HCC and Sex Hormones
3. Takeya Tsutsumi (Japan) : Mitochondria and Pathogenesis of HCV-associated HCC
4. Naoya Kato (Japan) : GWAS Analysis in HCV-associated HCC

Session 5
Diagnosis and Treatment of HCV-associated HCC
1. Ryosuke Tateishi (Japan) : Survey System and Treatment for Early HCC in Hepatitis C
2. Kwang-Hyub Han (Korea) : Treatment of HCC
3. Shi-Ming Lin (Taiwan) : Treatment of HCC
4. Shuhei Nishiguchi (Japan) : Prevention of HCC by IFN Therapies in Hepatitis C
5. Hitoshi Yoshiji (Japan) : Chemoprevention of HCV-associated HCC by BCAA and ARB

Session 6
Forefront of Antiviral Treatment for Hepatitis C
1. Michael P. Manns (Germany) : Hepatitis C Treatment in the Era of DAA
2. Kazuaki Chayama (Japan) : DAA Combination Therapy
3. Yasuhiro Asahina (Japan) : HCV Antivirals and IFN Signaling
4. Jacob George (Australia) Host Factors Influencing Antiviral Therapy for Hepatitis C
5. Yasuhito Tanaka (Japan) : Host Factors Influencing Antiviral Therapy for Hepatitis

Session 7
Management of Hepatitis C under Special Conditions
1. Jia-Horng Kao (Taiwan) : Coinfection with HBV
2. Ferruccio Bonino (Italy) : Coinfection with HBV
3. Jürgen K. Rockstroh (Germany) : Coinfection with HIV
4. Yasuhiko Sugawara (Japan) : Hepatitis C and Liver Transplantation